blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2686689

EP2686689 - METHODS PREDICTING RISK OF AN ADVERSE CLINICAL OUTCOME [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  10.07.2020
Database last updated on 14.11.2024
FormerThe patent has been granted
Status updated on  05.07.2019
FormerGrant of patent is intended
Status updated on  12.02.2019
FormerExamination is in progress
Status updated on  13.02.2017
Most recent event   Tooltip08.07.2022Lapse of the patent in a contracting state
New state(s): MK		published on 10.08.2022  [2022/32]
Applicant(s)For all designated states
Critical Care Diagnostics, Inc.
3030 Bunker Hill St.
Suite 115A
San Diego, California 92109 / US
[2014/04]
Inventor(s)01 / SNIDER, James, V.
13295 Calle del Campo
Unit 1
San Diego, CA 92129-4686 / US
 [2014/04]
Representative(s)Williams, Gareth Owen
Marks & Clerk LLP
62-68 Hills Road
Cambridge CB2 1LA / GB
[2019/32]
Former [2014/04]Williams, Gareth Owen
Marks & Clerk LLP
62-68 Hills Road
Cambridge
CB2 1LA / GB
Application number, filing date12771826.016.03.2012
[2019/32]
WO2012US29500
Priority number, dateUS201161453782P17.03.2011         Original published format: US 201161453782 P
[2014/04]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2012141844
Date:18.10.2012
Language:EN
[2012/42]
Type: A2 Application without search report 
No.:EP2686689
Date:22.01.2014
Language:EN
The application published by WIPO in one of the EPO official languages on 18.10.2012 takes the place of the publication of the European patent application.
[2014/04]
Type: B1 Patent specification 
No.:EP2686689
Date:07.08.2019
Language:EN
[2019/32]
Search report(s)International search report - published on:RU21.03.2013
(Supplementary) European search report - dispatched on:EP31.07.2014
ClassificationIPC:C07K14/47, C07K14/715, G01N33/53, G01N33/68
[2019/08]
CPC:
G01N33/6869 (EP,CN,US); G01N33/6893 (US); A61P9/00 (EP,US);
G01N33/53 (CN,US); G01N33/68 (US); C07K14/47 (US);
C07K14/4726 (US); C07K14/715 (US); G01N2333/4724 (EP,CN,US);
G01N2333/7155 (US); G01N2800/32 (EP,CN,US); G01N2800/325 (US);
G01N2800/50 (US); G01N2800/52 (EP,CN,US); G01N2800/54 (EP,CN,US);
G01N2800/56 (EP,CN,US) (-)
Former IPC [2014/04]G01N33/68, G01N33/53
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2014/04]
Extension statesBANot yet paid
MENot yet paid
TitleGerman:VERFAHREN ZUR VORHERSAGE DES RISIKOS EINER KLINISCHEN NEBENWIRKUNG[2014/04]
English:METHODS PREDICTING RISK OF AN ADVERSE CLINICAL OUTCOME[2014/04]
French:PROCÉDÉS DE PRÉDICTION DE RISQUE D'UN RÉSULTAT CLINIQUE INDÉSIRABLE[2014/04]
Entry into regional phase17.10.2013National basic fee paid 
17.10.2013Search fee paid 
17.10.2013Designation fee(s) paid 
17.10.2013Examination fee paid 
Examination procedure17.10.2013Examination requested  [2014/04]
27.02.2015Amendment by applicant (claims and/or description)
20.04.2015Despatch of a communication from the examining division (Time limit: M06)
16.10.2015Reply to a communication from the examining division
05.11.2015Despatch of a communication from the examining division (Time limit: M04)
15.03.2016Reply to a communication from the examining division
01.04.2016Despatch of a communication from the examining division (Time limit: M06)
05.10.2016Reply to a communication from the examining division
17.10.2016Despatch of a communication from the examining division (Time limit: M06)
27.04.2017Reply to a communication from the examining division
31.07.2017Despatch of a communication from the examining division (Time limit: M06)
02.02.2018Reply to a communication from the examining division
19.04.2018Despatch of a communication from the examining division (Time limit: M04)
14.08.2018Reply to a communication from the examining division
26.11.2018Despatch of a communication from the examining division (Time limit: M04)
27.11.2018Reply to a communication from the examining division
13.02.2019Communication of intention to grant the patent
21.06.2019Fee for grant paid
21.06.2019Fee for publishing/printing paid
21.06.2019Receipt of the translation of the claim(s)
Divisional application(s)EP19190278.2  / EP3605104
The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  20.04.2015
Opposition(s)03.06.2020No opposition filed within time limit [2020/33]
Fees paidRenewal fee
27.03.2014Renewal fee patent year 03
27.03.2015Renewal fee patent year 04
31.03.2016Renewal fee patent year 05
27.03.2017Renewal fee patent year 06
27.03.2018Renewal fee patent year 07
27.03.2019Renewal fee patent year 08
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU16.03.2012
AL07.08.2019
AT07.08.2019
CY07.08.2019
CZ07.08.2019
DK07.08.2019
EE07.08.2019
FI07.08.2019
HR07.08.2019
LT07.08.2019
LV07.08.2019
MC07.08.2019
MK07.08.2019
MT07.08.2019
NL07.08.2019
PL07.08.2019
RO07.08.2019
RS07.08.2019
SE07.08.2019
SI07.08.2019
SK07.08.2019
SM07.08.2019
TR07.08.2019
BG07.11.2019
NO07.11.2019
GR08.11.2019
IS07.12.2019
PT09.12.2019
IE16.03.2020
LU16.03.2020
BE31.03.2020
CH31.03.2020
LI31.03.2020
[2022/32]
Former [2022/27]HU16.03.2012
AL07.08.2019
AT07.08.2019
CY07.08.2019
CZ07.08.2019
DK07.08.2019
EE07.08.2019
FI07.08.2019
HR07.08.2019
LT07.08.2019
LV07.08.2019
MC07.08.2019
MT07.08.2019
NL07.08.2019
PL07.08.2019
RO07.08.2019
RS07.08.2019
SE07.08.2019
SI07.08.2019
SK07.08.2019
SM07.08.2019
TR07.08.2019
BG07.11.2019
NO07.11.2019
GR08.11.2019
IS07.12.2019
PT09.12.2019
IE16.03.2020
LU16.03.2020
BE31.03.2020
CH31.03.2020
LI31.03.2020
Former [2021/12]AL07.08.2019
AT07.08.2019
CZ07.08.2019
DK07.08.2019
EE07.08.2019
FI07.08.2019
HR07.08.2019
LT07.08.2019
LV07.08.2019
MC07.08.2019
NL07.08.2019
PL07.08.2019
RO07.08.2019
RS07.08.2019
SE07.08.2019
SI07.08.2019
SK07.08.2019
SM07.08.2019
TR07.08.2019
BG07.11.2019
NO07.11.2019
GR08.11.2019
IS07.12.2019
PT09.12.2019
IE16.03.2020
LU16.03.2020
BE31.03.2020
CH31.03.2020
LI31.03.2020
Former [2021/08]AL07.08.2019
AT07.08.2019
CZ07.08.2019
DK07.08.2019
EE07.08.2019
FI07.08.2019
HR07.08.2019
LT07.08.2019
LV07.08.2019
MC07.08.2019
NL07.08.2019
PL07.08.2019
RO07.08.2019
RS07.08.2019
SE07.08.2019
SI07.08.2019
SK07.08.2019
SM07.08.2019
TR07.08.2019
BG07.11.2019
NO07.11.2019
GR08.11.2019
IS07.12.2019
PT09.12.2019
IE16.03.2020
LU16.03.2020
CH31.03.2020
LI31.03.2020
Former [2021/04]AL07.08.2019
AT07.08.2019
CZ07.08.2019
DK07.08.2019
EE07.08.2019
FI07.08.2019
HR07.08.2019
LT07.08.2019
LV07.08.2019
MC07.08.2019
NL07.08.2019
PL07.08.2019
RO07.08.2019
RS07.08.2019
SE07.08.2019
SI07.08.2019
SK07.08.2019
SM07.08.2019
TR07.08.2019
BG07.11.2019
NO07.11.2019
GR08.11.2019
IS07.12.2019
PT09.12.2019
LU16.03.2020
Former [2020/49]AL07.08.2019
AT07.08.2019
CZ07.08.2019
DK07.08.2019
EE07.08.2019
FI07.08.2019
HR07.08.2019
LT07.08.2019
LV07.08.2019
MC07.08.2019
NL07.08.2019
PL07.08.2019
RO07.08.2019
RS07.08.2019
SE07.08.2019
SI07.08.2019
SK07.08.2019
SM07.08.2019
TR07.08.2019
BG07.11.2019
NO07.11.2019
GR08.11.2019
IS07.12.2019
PT09.12.2019
Former [2020/37]AL07.08.2019
AT07.08.2019
CZ07.08.2019
DK07.08.2019
EE07.08.2019
FI07.08.2019
HR07.08.2019
LT07.08.2019
LV07.08.2019
NL07.08.2019
PL07.08.2019
RO07.08.2019
RS07.08.2019
SE07.08.2019
SI07.08.2019
SK07.08.2019
SM07.08.2019
TR07.08.2019
BG07.11.2019
NO07.11.2019
GR08.11.2019
IS07.12.2019
PT09.12.2019
Former [2020/36]AL07.08.2019
AT07.08.2019
CZ07.08.2019
DK07.08.2019
EE07.08.2019
FI07.08.2019
HR07.08.2019
LT07.08.2019
LV07.08.2019
NL07.08.2019
PL07.08.2019
RO07.08.2019
RS07.08.2019
SE07.08.2019
SK07.08.2019
SM07.08.2019
TR07.08.2019
BG07.11.2019
NO07.11.2019
GR08.11.2019
IS07.12.2019
PT09.12.2019
Former [2020/27]AL07.08.2019
AT07.08.2019
CZ07.08.2019
DK07.08.2019
EE07.08.2019
FI07.08.2019
HR07.08.2019
LT07.08.2019
LV07.08.2019
NL07.08.2019
PL07.08.2019
RO07.08.2019
RS07.08.2019
SE07.08.2019
SK07.08.2019
SM07.08.2019
TR07.08.2019
BG07.11.2019
NO07.11.2019
GR08.11.2019
PT09.12.2019
IS24.02.2020
Former [2020/25]AL07.08.2019
AT07.08.2019
CZ07.08.2019
DK07.08.2019
EE07.08.2019
FI07.08.2019
HR07.08.2019
LT07.08.2019
LV07.08.2019
NL07.08.2019
PL07.08.2019
RO07.08.2019
RS07.08.2019
SE07.08.2019
SK07.08.2019
TR07.08.2019
BG07.11.2019
NO07.11.2019
GR08.11.2019
PT09.12.2019
IS24.02.2020
Former [2020/24]AL07.08.2019
AT07.08.2019
DK07.08.2019
EE07.08.2019
FI07.08.2019
HR07.08.2019
LT07.08.2019
LV07.08.2019
NL07.08.2019
PL07.08.2019
RO07.08.2019
RS07.08.2019
SE07.08.2019
TR07.08.2019
BG07.11.2019
NO07.11.2019
GR08.11.2019
PT09.12.2019
IS24.02.2020
Former [2020/23]AL07.08.2019
AT07.08.2019
DK07.08.2019
EE07.08.2019
FI07.08.2019
HR07.08.2019
LT07.08.2019
LV07.08.2019
NL07.08.2019
PL07.08.2019
RO07.08.2019
RS07.08.2019
SE07.08.2019
TR07.08.2019
BG07.11.2019
NO07.11.2019
GR08.11.2019
IS07.12.2019
PT09.12.2019
Former [2020/22]AL07.08.2019
DK07.08.2019
EE07.08.2019
FI07.08.2019
HR07.08.2019
LT07.08.2019
LV07.08.2019
NL07.08.2019
RS07.08.2019
SE07.08.2019
TR07.08.2019
BG07.11.2019
NO07.11.2019
GR08.11.2019
IS07.12.2019
PT09.12.2019
Former [2020/17]AL07.08.2019
FI07.08.2019
HR07.08.2019
LT07.08.2019
LV07.08.2019
NL07.08.2019
RS07.08.2019
SE07.08.2019
TR07.08.2019
BG07.11.2019
NO07.11.2019
GR08.11.2019
IS07.12.2019
PT09.12.2019
Former [2020/15]AL07.08.2019
FI07.08.2019
HR07.08.2019
LT07.08.2019
LV07.08.2019
NL07.08.2019
RS07.08.2019
SE07.08.2019
BG07.11.2019
NO07.11.2019
GR08.11.2019
IS07.12.2019
PT09.12.2019
Former [2020/12]FI07.08.2019
HR07.08.2019
LT07.08.2019
LV07.08.2019
NL07.08.2019
RS07.08.2019
SE07.08.2019
BG07.11.2019
NO07.11.2019
GR08.11.2019
IS07.12.2019
PT09.12.2019
Former [2020/11]FI07.08.2019
HR07.08.2019
LT07.08.2019
LV07.08.2019
NL07.08.2019
RS07.08.2019
SE07.08.2019
BG07.11.2019
NO07.11.2019
GR08.11.2019
PT09.12.2019
Former [2020/10]FI07.08.2019
LT07.08.2019
NL07.08.2019
SE07.08.2019
BG07.11.2019
NO07.11.2019
PT09.12.2019
Former [2020/09]FI07.08.2019
LT07.08.2019
NL07.08.2019
NO07.11.2019
Former [2020/08]LT07.08.2019
NO07.11.2019
Documents cited:Search[Y]WO2007127749  (CRITICAL CARE DIAGNOSTICS INC [US], et al) [Y] 1-15 * claims 1-52 ** example 9 *;
 [X]  - JAMES L JANUZZI ET AL, "Importance of Biomarkers for Long-Term Mortality Prediction in Acutely Dyspneic Patients", CLINICAL CHEMISTRY, (20101004), vol. 56, no. 12, doi:10.1373/clinchem.2010.146506, pages 1814 - 1821, XP055130850 [X] 1-15 * the whole document *

DOI:   http://dx.doi.org/10.1373/clinchem.2010.146506
 [XI]  - REHMAN S U ET AL, "Independent and incremental prognostic value of multimarker testing in acute dyspnea: Results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) study", CLINICA CHIMICA ACTA, ELSEVIER BV, AMSTERDAM, NL, vol. 392, no. 1-2, doi:10.1016/J.CCA.2008.03.002, ISSN 0009-8981, (20080601), pages 41 - 45, (20080313), XP022637367 [X] 1,15 * the whole document * [I] 1-15

DOI:   http://dx.doi.org/10.1016/j.cca.2008.03.002
 [Y]  - Shanmugam Uthamalingam ET AL, "Heart Failure Novel Applications of Cardiac Biomarkers in Heart Failure Novel Applications of Established Cardiac Biomarkers-Natriuretic Peptides", (20090101), URL: http://www.radcliffecardiology.com/sites/www.touchcardiology.com/files/private/articles/9709/pdf/januzzi0.pdf, (20140722), XP055130806 [Y] 1-15 * the whole document *
International search[A]US2002155513  (HSU DANIEL K [US], et al);
 [A]US2006257946  (DING JIAN [US], et al);
 [Y]  - RAVI V.SHAH ET AL., "Galectin-3, cardiac structure and function, and long-term mortality in patients with acutely decompensated heart failure", EUROPEAN JOURNAL OF HEART FAILURE, (2010), vol. 12, pages 826 - 832, XP055125266

DOI:   http://dx.doi.org/10.1093/eurjhf/hfq091
 [Y]  - MASAHISA SHIMPO ET AL., JOURNAL OF THE AMERICAN HEART ASSOCIATION, (200405), vol. 109, no. 18, pages 2186 - 2190, XP002523097

DOI:   http://dx.doi.org/10.1161/01.CIR.0000127958.21003.5A
by applicantUS6176962
 US6517234
 US2003124624
 US2004048286
 US2005130136
 US2005250156
 WO2007127749
 WO2011127412
 US2011256635
    - "NCBI", Database accession no. NP 003847.2
    - "NCBI", Database accession no. NM - 003856.2
    - "NCBI", Database accession no. 001170859
    - "NCBI", Database accession no. NP_002297
    - "NCBI", Database accession no. NM_001177388.1
    - "NCBI", Database accession no. NM 002306.3
    - "NCBI", Database accession no. NP001170859
    - "NCBI", Database accession no. NP 002297
    - "NCBI", Database accession no. NM _001177399.1
    - "NCBI", Database accession no. NM -002306.3
    - SHARMA et al., Circulation, (20040000), vol. 110, pages 3121 - 3128
    - DE BOER et al., Eur. J. Heart Failure, (20090000), vol. 11, pages 811 - 817
    - YANG et al., Expert Rev. Mol. Med., (20080000), vol. 13, pages e17 - e39
    - JESSUP et al., Circulation, (20090000), vol. 48, pages 1217 - 1224
    - VAN KIMMENADE et al., J. Am. Coll. Cardiol., (20060000), vol. 48, pages 1217 - 1224
    - LOK et al., Clin. Res. Cardiol., (20100000), vol. 99, pages 323 - 328
    - Current Protocols in Molecular Biology, John Wiley & Sons, (19890000), pages 6.3.1 - 6.3.6
    - LE DOUSSAL et al., New Engl. J. Med., (19910000), vol. 146, pages 169 - 175
    - GIBELLINI et al., J. Immunol., (19980000), vol. 160, pages 3891 - 3898
    - HSING; BISHOP, New Engl. J. Med., (19990000), vol. 162, pages 2804 - 2811
    - EVERTS et al., New Engl. J. Med., (20020000), vol. 168, pages 883 - 889
    - WU, Recombinant DNA, Academic Press, (19930000), vol. 217
    - AUSBEL et al., Current Protocols in Molecular Biology, John Wiley and Sons, Inc., (20010000), vol. 1-4
    - KIESER et al., FEBS Lett., (19950000), vol. 372, no. 2-3, pages 189 - 93
    - KUMAR et al., J. Biol. Chem., (19950000), vol. 270, no. 46, pages 27905 - 13
    - YANAGISAWA et al., FEBS Lett., (19920000), vol. 302, no. l, pages 51 - 3
    - KUROIWA et al., Hybridoma, (20000000), vol. 19, no. 2, pages 151 - 9
    - WEINBERG et al., Circulation, (20020000), vol. 106, no. 23, pages 2961 - 6
    - WEINBERG et al., Circulation, (20030000), vol. 107, no. 5, pages 721 - 6
    - SHIMPO et al., Circulation, (20040000), vol. 109, no. 18, pages 2186 - 90
    - JANUZZI et al., Clinical Chemistry, (20100000), vol. 56, no. 12, pages 1814 - 1821
    - REHMAN et al., Clinica ChimicaActa., (20080000), vol. 392, no. 1-2, pages 41 - 45
    - UTHAMALINGAM et al., US Cardiology, (20090000), vol. 6, no. 1, pages 41 - 45
    - LOHNING et al., Proc. Natl. Acad. Sci. U.S.A., (19980000), vol. 95, no. 12, pages 6930 - 6935
    - SCHMITZ et al., Immunity, (20050000), vol. 23, no. 5, pages 479 - 90
    - BRINT et al., Nat. Immunol., (20040000), vol. 5, no. 4, pages 373 - 9
    - BRUNEAU et al., Cardiovasc. Res., (19940000), vol. 28, no. 10, pages 1519 - 25
    - TOMINAGA, FEBS Lett., (19890000), vol. 258, pages 301 - 304
    - TOMINAGA et al., Biochim. Biophys. Acta, (19920000), vol. 1171, pages 215 - 218
    - "GenBank", Database accession no. NM 003856.2
    - "GenBank", Database accession no. NP 003847.2
    - "GenBank", Database accession no. NM_016232.4
    - "GenBank", Database accession no. NP_057316.3
    - "NCBI", Database accession no. NP_003847.2
    - "NCBI", Database accession no. NM 003856.2
    - JANUZZI et al., Arch. Intern. Med., (20060000), vol. 166, no. 3, pages 315 - 320
    - JANUZZI et al., Am. J. Cardiol., (20050000), vol. 95, no. 8, pages 948 - 954
    - MCKEE et al., N. Engl. J. Med., (19710000), vol. 285, no. 26, pages 1441 - 1446
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.